Effect of dosing interval between edaravone and cefalotin/glycerol on the nephrotoxicity in rats(Kidney, Urinary system, Proceedings of the 32nd Annual Meeting)

• OHYAMA Naoki

  Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation

• ISHII Shun-ichiro

  Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation

• SHIBATA Hiroshi

  Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation

• OKADA Miyoko

  Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation

• INOUE Yoshimi

  Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation

• SUGIMOTO Jiro

  Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation

• SHINTAKU Yoshihisa

  Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation

• SUGIYAMA Akio

  Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation

• MUTAI Mamoru

  Toxicology Laboratory, Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation

収録刊行物

• Journal of toxicological sciences

  Journal of toxicological sciences 30 (0), S88-, 2005-10-31

  日本毒性学会

詳細情報

• CRID: 1570854177017358080
• NII論文ID: 110004041777
• NII書誌ID: AN00002808
• ISSN: 03881350
• Web Site: https://search.jamas.or.jp/link/ui/2006294722
• 本文言語コード: en
• データソース種別:
  • CiNii Articles